Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 5:41 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 841–864 of 12,232 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Multiple Diseases Clear all

Conditions: Postpartum Depression (PPD)
Interventions: SAINT Neuromodulation System, Sham SAINT Stimulation; Device
Lead sponsor: Magnus Medical; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 192 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 4
States / cities: Worcester, Massachusetts • New York, New York • Charleston, South Carolina + 1 more

Conditions: Cytomegalovirus Infection
Interventions: DBS Self-Collection Kit, Standard Control Strategy; Device · Other
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 15 Years to 99 Years
Enrollment: 622 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 4
States / cities: Minneapolis, Minnesota • New York, New York • Houston, Texas + 1 more

Conditions: Refractory Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
Interventions: melphalan, amifostine trihydrate, peripheral blood stem cell transplantation, fluorescence in situ hybridization, bone marrow ablation with stem cell support; Drug · Procedure · Genetic
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: 18 Years to 70 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 4
States / cities: Los Angeles, California • Rochester, New York • Seattle, Washington

Conditions: Breast Cancer
Interventions: IORT with CT-Guided HDR Brachytherapy; Device
Lead sponsor: Shayna Showalter, MD; Other
Eligibility: 45 Years and older · Female only
Enrollment: 358 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2027
U.S. locations: 3
States / cities: Hackensack, New Jersey • Philadelphia, Pennsylvania • Charlottesville, Virginia

Conditions: Healthy, Neurodegenerative Disease
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 200,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2030
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Renal Dialysis, Kidney Failure, Chronic
Interventions: MK-2060, Placebo; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 3
States / cities: Orlando, Florida • Saint Paul, Minnesota • Knoxville, Tennessee

Conditions: Spinal Cord Injury, Stroke (CVA) or Transient Ischemic Attack, Multiple Sclerosis
Interventions: Neural Prosthesis; Device
Lead sponsor: Louis Stokes VA Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2034
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Stress, Quality, Anxiety, Resilience
Interventions: Stress Management and Resilience Training; Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 5
States / cities: Mountain Home, Idaho • Baltimore, Maryland • Las Vegas, Nevada + 2 more

Conditions: Septic Shock
Interventions: LB1148, Placebo; Drug
Lead sponsor: Leading BioSciences, Inc; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 26
States / cities: Mobile, Alabama • Fresno, California • Long Beach, California + 23 more

Conditions: Multiple Myeloma, Myeloma, Disability Physical, Disabilities Multiple
Interventions: Supportive care interventions; Other
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 60 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Down Syndrome
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 6 Years to 35 Years
Enrollment: 202 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 2
States / cities: Fort Collins, Colorado • Cincinnati, Ohio

Conditions: Tinea Cruris
Interventions: 33525, Placebo; Drug
Lead sponsor: Medicis Global Service Corporation; Industry
Eligibility: 12 Years and older
Enrollment: 483 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 17
States / cities: Fremont, California • Los Angeles, California • Miami, Florida + 14 more

Conditions: Drug Interactions, Primary Prevention, Cardiometabolic Syndrome, LDL-Cholersterol Lowering, Polypharmacy
Interventions: Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Degenerative Disc Disease
Interventions: NuBac, Prodisc-L; Device
Lead sponsor: Pioneer Surgical Technology, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 17
States / cities: Beverly Hills, California • Colton, California • Loma Linda, California + 13 more

Conditions: Cancer, Cancer Diagnosis
Interventions: GRAIL Galleri MCED test; Device
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 22 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obesity
Interventions: Communications, Pricing, Combined (Communications & Pricing); Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 21 Years to 100 Years
Enrollment: 444 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Respiratory Syncytial Virus Infection, Healthy Volunteers, Human Metapneumovirus
Interventions: RSV/hMPV vaccine candidate Dose L, RSV/hMPV vaccine candidate Dose A, RSV/hMPV vaccine candidate Dose B, Placebo; Biological
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Eligibility: 60 Years and older
Enrollment: 646 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 10
States / cities: Los Alamitos, California • Los Angeles, California • Rolling Hills Estates, California + 7 more

Conditions: Relapsing Remitting Multiple Sclerosis
Interventions: Modified Atkins diet; Other
Lead sponsor: University of Virginia; Other
Eligibility: 12 Years to 55 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Multiple Myeloma
Interventions: cytogenetic analysis; Genetic
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 9,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1984
U.S. locations: 137
States / cities: La Jolla, California • Mountain View, California • San Diego, California + 89 more

Conditions: Primary Ciliary Dyskinesia
Interventions: RCT1100; Drug
Lead sponsor: ReCode Therapeutics; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Multiple Sclerosis
Interventions: dimethyl fumarate; Drug
Lead sponsor: Biogen; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 15
States / cities: Gilbert, Arizona • Phoenix, Arizona • Long Beach, California + 12 more

Conditions: Advanced Solid Tumours, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Ductal Adenocarcinoma (PDAC), Colorectal Cancer (CRC)
Interventions: AZD0022, Cetuximab; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 3
States / cities: Duarte, California • New York, New York • Fairfax, Virginia

Conditions: Multiple Myeloma in Relapse
Interventions: Panobinostat, Dexamethasone, Lenalidomide, Bortezomib; Drug
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2021
U.S. locations: 4
States / cities: Boston, Massachusetts • Durham, North Carolina

Conditions: Multiple Sclerosis, Back Pain
Interventions: home - exercise program; Other
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 50 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Little Rock, Arkansas

Search by objective public record fields.

SAINT in Postpartum Depression (PPD)

Dried Blood Spot Testing of CMV Detection in HCT Recipients

Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

Brain Health Registry: An Online Registry to Identify and Assess Subjects for Brain Research

Safety and Pharmacokinetics of MK-2060 in Older Participants With End-Stage Renal Disease on Hemodialysis (MK-2060-004)

Understanding and Enhancing Human Health and Movement

Resiliency in U.S. Air Force Personnel

Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148

Geriatric-assessment Interventions to Address Functional Deficits in Older Adults w Multiple Myeloma

Evaluating Cognitive Outcomes in Down Syndrome

Topical Antifungal Treatment for Tinea Cruris

LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering

Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

The DISCOVER Study

Multi-level Communications and Access Strategies to Improve the Food Environment

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

Utilization of the Ketogenic Diet in Patient With Relapsing Remitting MS

Cytogenetic Studies in Acute Leukemia and Multiple Myeloma

Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects

Tecfidera Slow-Titration Study

A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation

A Phase I Study Of Panobinostat/Lenalidomide/Bortezomib/Dex for Relapsed And Relapsed/Refractory Multiple Myeloma

A Pilot Project for Multifidus Muscle Evaluation in Patients With Multiple Sclerosis